NRG
27
2
CLX
63
4
AZO
42
-3
LUV
42
3
SBUX
31
2
COF
45
3
NAVI
40
5
MMM
32
6
EFX
40
2
PCG
50
3
CCL
62
2
JPM
53
3
SPG
43
2
EXPD
27
-2
INTC
31
2
MAC
48
-3
PNR
54
3
HAL
29
-10
PGR
45
-4
UHS
46
2
NRG
27
2
CLX
63
4
AZO
42
-3
LUV
42
3
SBUX
31
2
COF
45
3
NAVI
40
5
MMM
32
6
EFX
40
2
PCG
50
3
CCL
62
2
JPM
53
3
SPG
43
2
EXPD
27
-2
INTC
31
2
MAC
48
-3
PNR
54
3
HAL
29
-10
PGR
45
-4
UHS
46
2
Financhill
Back

Greenlight Capital Re Vs. Aligos Therapeutics Industry Stock Comparison

Buy
59

GLRE
Greenlight Capital Re

Last Price:
$14.04
Seasonality Move:
0.62%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$39.51
Seasonality Move:
7.18%
Buy
59
Greenlight Capital Re (GLRE) is a Buy

Is Greenlight Capital Re a Buy, Sell or Hold?

  • The current Greenlight Capital Re [GLRE] share price is $13.90. The Score for GLRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

  • The Greenlight Capital Re share price today is $13.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLRE is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $38.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 30.72 Sell
Chaikin Money Flow: -38384 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.43 - 15.07) Sell
Bollinger Bands (100): (13.22 - 14.62) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.1 Buy
Relative Strength Index (14 RSI): 79.33 Buy
Chaikin Money Flow: 265554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.3 - 32.5) Buy
Bollinger Bands (100): (7.16 - 22.66) Buy

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.51 Sell
20-day SMA: 14.79 Sell
50-day SMA: 14.33 Sell
200-day SMA: 13.3 Buy
8-day EMA: 14.39 Sell
20-day EMA: 14.58 Sell
50-day EMA: 14.39 Sell
200-day EMA: 13.34 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Buy
20-day SMA: 28.23 Buy
50-day SMA: 17.95 Buy
200-day SMA: 16.14 Buy
8-day EMA: 33.62 Buy
20-day EMA: 28.8 Buy
50-day EMA: 21.66 Buy
200-day EMA: 17.2 Buy

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Greenlight Capital Re Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):